New scan could spot hidden artery disease faster
NCT ID NCT06335888
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new type of PET/CT scan (AzaFol) to see if it can better diagnose giant cell arteritis, a condition that causes inflamed blood vessels. About 70 people with suspected GCA will get the new scan and a standard scan to compare accuracy. The goal is to improve diagnosis and reduce the need for invasive biopsies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Rheumatology and Immunology, University Hospital Bern, Inselspital
RECRUITINGBern, 3010, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune clues in the blood may foretell heart trouble
- New tool could predict who will suffer from steroid side effects
- Shorter steroid course may be just as effective for giant cell arteritis
- New Total-Body PET scanner could revolutionize vasculitis diagnosis
- New study links common arthritis treatments to diabetes risk
- Eye ultrasound could help doctors spot hidden inflammation in blood vessel disease